PubMed · 1965 · 133 citations · 333 references
Life SciencesBiochemistryLipid BiochemistryNutritional BiochemistryProtein BiochemistryCholesterol MetabolismLipid DisordersLipid MetabolismLipid Metabolism DisordersLipoprotein AnalysisLipoprotein MetabolismGenetic Lipid DisordersLipoprotein BindingLipoprotein Metabolism RegulationProtein ProductionTangier DiseaseTriglyceride-rich Lipoproteins
This chapter discusses the factors that affect the metabolism of lipoproteins. It is now widely accepted that water-insoluble lipids circulate in plasma bound to specific proteins to yield soluble macromolecular complexes, lipoproteins, which vary in lipid complement and nature of their protein moiety. Rapid progress in lipid technology has led to important analytical data on the lipoprotein lipids, although their structural arrangement in each plasma lipoprotein remains undetermined. It is possible that some disorders of lipid metabolism may arise from primary qualitative and quantitative abnormalities of lipoprotein protein production. Genetic disorders, such as Tangier disease or acanthocytosis, could be included in this category. Neither the relative contribution of the protein and lipid moieties in the overall metabolism of the plasma lipoprotein is known nor is the role of their carbohydrate moiety. Abnormalities in the distribution of the three main lipoprotein classes, VLDL, LDL, and HDL, have now been recognized under a variety of conditions: hormonal imbalance, drug administration, dietary changes, and genetic factors. In each instance, the basic defect still remains undetermined, partially a reflection of lack of understanding of the mechanisms that physiologically regulate lipoprotein metabolism.
333
F. Plum · Archives of Neurology · 1960 · 10.4K citations
The Role of Lipids and Lipoproteins in Atherosclerosis
John W. Gofman, Frank T. Lindgren, Harold A. Elliott et al. · Science · 1950 · 937 citations
Medicine, Cardiology, Aging +10